Parallel Bio’s head of technology shares a vision for faster, cheaper, and better biological research with human organoids. Ari Gesher, Parallel Bio’s new head of technology, may be new to biotech, but that’s not stopping him from thinking big about disrupting the status quo in biological research. The biotech startup is betting on automation and…
How the replication crisis threatens R&D and what to do about it
Let’s say you are repeating a scientific experiment but each time you’re getting a completely different outcome. This is the frustrating reality of the “replication crisis,” a widespread problem affecting nearly every scientific discipline. “We’ve all seen in our own practices how there are many ‘researcher degrees of freedom’ that could lead to studies not…
Is your R&D data holding you back? Here’s how you can flip the script
In the high-stakes product development race, R&D teams are facing relentless pressure. Every day, every experiment, is a tightrope walk between painstaking research and the need for speed to outpace the competition. But what if the very data that underpins your R&D efforts is actually putting you in the slow lane? R&D is an expedition…